Drug Development Outsourcing Provides Opportunities for Clinical Trial Management Systems Market: companiesandmarkets.com

LONDON--(BUSINESS WIRE)-- It is expected that the clinical trial management systems (CTMS) market will achieve a value of $1.76 billion by 2017, according to a new report on companiesandmarkets.com. Pharmaceutical companies are seeking opportunities to reduce costs associated with drug development, and increasingly complex Phase IV trials are driving market demand for technology which can cope with the demands of present and future clinical trials.

Automotive Software: A Global Strategic Business Report

http://www.companiesandmarkets.com/Market-Report/clinical-trial-management-systems-(ctms)-a-global-strategic-business-report-618118.asp?prk=7c4ed5b510c1ffe12b50d9829eddaba2

Drug development pipelines are reducing and outsourcing is increasing, subsequently providing more opportunities for the clinical trial management systems market. The US is the largest clinical trial management systems (CTMS) market, and represents a distinct growth opportunity, as many of its clinical trials operations have yet to adopt electronic management technologies. The second largest market, Europe, is considerably behind the US; while growth in the Asia-Pacific region is expected to increase at an accelerated rate of 14.4% p/a.

Clinical trial management systems companies are looking to enhance their propositions with more innovative solutions, particularly in the field of regulatory compliance. The clinical trial management systems report indicates that improvements could help pharmaceutical companies to save between $10-$12 million p/a.

Within the report are profiles of 75 companies active in the clinical trial management systems market, including Winchester Business Systems; Aris Global LLC; StudyManager Inc; Medidata Solutions; BioClinica Inc; eClinForce Inc; Nextrials Inc; Perceptive Informatics Inc; Bio-Optronics In; eResearch Technology Inc; MedNet Solutions; Clinical Force Inc; DSG Inc; Oracle; Integrated Clinical Solutions Inc and Merge eClinical Inc.

The 412 page report examines the clinical trial management systems market, including historic and forecast data for 2003-2017. The report is split by the following geographies: Asia Pacific, Canada, Europe (comprising France, Germany, Italy, UK, and Rest of Europe), Japan, US and Rest of World. The US market is broken down further by product: Application Software, Middleware and Operating System. Discussion of trends; market drivers/barriers; products and other market-influencing factors, is also included.

Report Details:

http://www.companiesandmarkets.com/Market-Report/clinical-trial-management-systems-(ctms)-a-global-strategic-business-report-618118.asp?prk=7c4ed5b510c1ffe12b50d9829eddaba2



CONTACT:

Companies & Markets
Paul Chapman
Press Office
[email protected]
London (UK): +44 (0) 203 086 8600

KEYWORDS:   United Kingdom  Europe

INDUSTRY KEYWORDS:   Health  Biotechnology  Clinical Trials  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.